|
|
||||||||||||||
|
|
|||||||||||||||
SHORT REPORT |
1 Department of Neurology, University of Bonn, Bonn, Germany
2 Department of Nuclear Medicine, University of Bonn
3 Department of Epileptology, University of Bonn
4 Department of Nuclear Medicine, University of Munich, Munich, Germany
Correspondence to:
Correspondence to:
Dr Ullrich Wüllner
Department of Neurology, University of Bonn, Sigmund-Freud-Strasse 25, Bonn 53105, Germany; wuellner{at}uni-bonn.de
ABSTRACT
Background: Mitochondrial disorders may affect basal ganglia function. In addition, decreased activity of complex I of the mitochondrial electron transport chain has been linked to the pathogenesis of dopaminergic cell loss in Parkinsons disease.
Objective : To investigate the dopaminergic system in patients with known mitochondrial disorders and complex I deficiency.
Methods: Dopamine transporter density was studied in 10 female patients with mitochondrial complex I deficiency by 123I-FP-CIT (N-ß-fluoropropyl-2ß-carbomethyl-3ß-(4-iodophenyl)-nortropane) SPECT.
Results: No differences in 123I-FP-CIT striatal binding ratios were observed and no correlation of the degree of complex I deficiency and striatal binding ratios could be detected.
Conclusions: These data argue against the possibility that mitochondrial complex I deficiency by itself is sufficient to elicit dopaminergic cell loss.
Abbreviations: CPEO, chronic progressive external ophthalmoplegia; DAT, dopamine transporter; SPECT, single photon emission computed tomography
Keywords: dopamine; 123 I-FP-CIT SPECT; mitochondrial disorders
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |